Agrawal Drugs And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.95 M
as on 17-12-2024
- Paid Up Capital ₹ 1.81 M
as on 17-12-2024
- Company Age 39 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.80 M
as on 17-12-2024
- Revenue 60.29%
(FY 2022)
- Profit -12.11%
(FY 2022)
- Ebitda -7.47%
(FY 2022)
- Net Worth 11.95%
(FY 2022)
- Total Assets 11.63%
(FY 2022)
About Agrawal Drugs And Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.95 M and a paid-up capital of Rs 1.81 M.
The company has closed loans amounting to ₹1.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ravindra Agrawal, Pradeep Pathak, and Nikunj Agrawal serve as directors at the Company.
- CIN/LLPIN
U24232MP1985PTC002800
- Company No.
002800
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 1985
- Date of AGM
23 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Agrawal Drugs And Chemicals?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ravindra Agrawal | Director | 01-Nov-1994 | Current |
Pradeep Pathak | Director | 21-Jan-1997 | Current |
Nikunj Agrawal | Director | 26-May-2010 | Current |
Financial Performance of Agrawal Drugs And Chemicals.
Agrawal Drugs And Chemicals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 60.29% increase. The company also saw a substantial fall in profitability, with a 12.11% decrease in profit. The company's net worth Soared by an impressive increase of 11.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Agrawal Drugs And Chemicals?
Unlock access to Agrawal Drugs And Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Kin Drugs & Chemicals Pvt Ltd.Active 35 years 6 months
Ravindra Agrawal and Nikunj Agrawal are mutual person
- Ravikiran Textiles Pvt. Ltd.Active 35 years 4 months
Ravindra Agrawal and Nikunj Agrawal are mutual person
- Ravikiran Rasayan Distributors Pvt. Ltd.Active 35 years 4 months
Ravindra Agrawal and Nikunj Agrawal are mutual person
- Kiran Land Skapers Pvt.Ltd.Active 33 years 7 months
Ravindra Agrawal and Nikunj Agrawal are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of Indore Creation Date: 27 Jun 1990 | ₹0.90 M | Satisfied |
State Bank Of Indore Creation Date: 31 Mar 1987 | ₹0.90 M | Satisfied |
How Many Employees Work at Agrawal Drugs And Chemicals?
Agrawal Drugs And Chemicals has a workforce of 16 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agrawal Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrawal Drugs And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.